Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Qualys Inc.

Start price
Target price
Perf. (%)
€117.60
30.11.21
-
30.11.22
-3.32%
02.03.22

buy
Builders Firstsource

Start price
Target price
Perf. (%)
€62.00
30.11.21
-
30.11.22
9.68%
02.03.22

buy
Moderna Inc.

Start price
Target price
Perf. (%)
€319.25
29.11.21
-
29.11.22
-47.84%
30.11.22

Fair valuation
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Standard Investments for future growth
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€322.25
29.11.21
-
29.11.25
-69.69%
12.01.24

Top 10 in its market
Could be worthwhile Investment >10% per year
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€264.10
27.11.21
€300.00
31.12.23
-46.31%
08.05.23

Could be worthwhile Investment >10% per year
buy
Bruker Corp.

Start price
Target price
Perf. (%)
€75.50
27.11.21
€100.00
31.12.23
-5.30%
08.05.23

Could be worthwhile Investment >10% per year
buy
Zoom Video Communications Inc

Start price
Target price
Perf. (%)
€201.45
27.11.21
€230.00
31.12.23
-71.40%
08.05.23

Could be worthwhile Investment >10% per year
Zynga Inc.

Start price
Target price
Perf. (%)
€5.74
27.11.21
€4.80
27.11.22
39.69%
14.03.22

Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€152.65
16.11.21
€200.00
31.01.25
36.59%
03.08.22

Could be worthwhile Investment >10% per year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€199.52
14.11.21
€230.00
14.11.22
-19.81%
18.03.22

Could be worthwhile Investment >10% per year
buy
Zynga Inc.

Start price
Target price
Perf. (%)
€6.55
11.11.21
€7.80
11.11.22
-12.31%
27.11.21

Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
Bluebird Bio Inc.

Start price
Target price
Perf. (%)
€9.23
09.11.21
€7.00
31.12.23
-56.18%
28.06.22

Could be very worthwhile Investment >20% year
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€193.66
05.11.21
-
05.11.22
3.03%
14.11.21

Risky Investment
Moderna Inc.

Start price
Target price
Perf. (%)
€191.52
05.11.21
-
05.11.22
4.18%
14.11.21

Could be worthwhile Investment >10% per year
Avis Budget Group

Start price
Target price
Perf. (%)
€279.40
02.11.21
-
02.11.22
-21.49%
10.11.21

Probably not worthwhile Investment
buy
Ipg Photonics

Start price
Target price
Perf. (%)
€140.30
01.11.21
€180.00
01.11.22
-38.63%
02.11.22

Could be worthwhile Investment >10% per year
buy
Ipg Photonics

Start price
Target price
Perf. (%)
€140.30
01.11.21
€180.00
01.11.22
-38.63%
02.11.22

Could be worthwhile Investment >10% per year
Zynga Inc.

Start price
Target price
Perf. (%)
€6.30
01.11.21
€5.00
01.11.22
3.92%
11.11.21

Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
buy
Acceleron Pharma Inc.

Start price
Target price
Perf. (%)
€149.00
30.10.21
€180.00
31.12.23
6.71%
08.05.23

Could be very worthwhile Investment >20% year
buy
Global Blood Therapeutics Inc

Start price
Target price
Perf. (%)
€33.09
30.10.21
€45.00
31.12.23
94.65%
05.08.22

Could be very worthwhile Investment >20% year
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€180.85
16.10.21
€160.00
16.10.22
-6.22%
24.10.21

Could be worthwhile Investment >10% per year
buy
Mandiant Inc.

Start price
Target price
Perf. (%)
€15.36
12.10.21
-
12.10.22
-0.20%
25.10.21

Helmerich & Payne Inc

Start price
Target price
Perf. (%)
€26.92
09.10.21
-
09.10.22
-22.10%
17.12.21

Capable Management
Business model of the past or high risk
Sustainability is little important
buy
iRobot Corp.

Start price
Target price
Perf. (%)
€70.42
09.10.21
-
09.10.22
-28.00%
22.02.22

Some uniques
Differentiated customer and product portfolio
Revenue growth >5% per year expected
Very positive Cash Flow expected
DISH Network Corp. A

Start price
Target price
Perf. (%)
€38.64
01.10.21
-
01.10.22
-52.68%
18.08.22

Higher risks for its business
Very low/no dividend yield expected
Few uniques